Growing Region Segmentation Software (GRES) for quantitative magnetic resonance imaging of multiple sclerosis: Intra- and inter-observer agreement variability: A comparison with manual contouring method

European Radiology

Volumn 12, Issue 4, 2002, Pages 866-871

  Parodi, Roberto C ^a   Sardanelli, Francesco ^a   Renzetti, Paolo ^a   Rosso, Elisabetta ^a   Losacco, Caterina ^a   Ferrari, Alessandra ^b   Levrero, Fabrizio ^b   Pilot, Alberto ^b   Inglese, Matilde ^a   Mancardi, Giovanni L ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Brain MRI; Intra and inter observer agreement; Lesion volume measurements; Multiple sclerosis

Indexed keywords

GADODIAMIDE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE COURSE; HUMAN; INTERMETHOD COMPARISON; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZATION; TREATMENT OUTCOME; ALGORITHM; BRAIN; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY;

ALGORITHMS; BRAIN; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OBSERVER VARIATION; SOFTWARE;

EID: 0036551128     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300100978     Document Type: Article

References (18)

1. Rao SM, Leo GJ, Haughton VM, St. Aubin-Faubert P, Bernardin L (1989) Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 39: 161-166
2. The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, doubleblind, placebo-controlled trial. Neurology 43: 655-661
3. Paty DW, Li DKB, The UBC MS/MRI Study Group and the IFNB Multiple Sclerosis study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 662-667
4. Filippi M, Horsfield MA, Morrissey SP et al. (1994) Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 44: 635-641
5. Isaac C, Li DKB, Genton M et al. (1988) Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 38: 1511-1515
6. McFarland HF, Frank JA, Albert PS et al. (1992) Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32: 758-766
7. Paty DW, Li DKB, Oger JJF et al. (1994) Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 36:S95-S96
8. Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH (1995) Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 118: 1601-1612
9. Stone LA, Albert PS, Smith ME et al. (1995) Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology 45: 1808-1814
10. Kappos L, Stadt D, Ratzka M et al. (1988) Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 30: 299-302
11. Moreau T, Thorpe J, Miller DH et al. (1994) Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet 344: 298-301
12. Mancardi GL, Sardanelli F, Parodi RC et al. (1998) The effect of Coplymer-1 on serial gadolinium-enhanced MRI in relapsing-remitting multiple sclerosis. Neurology 50: 1127-1133
13. Jacobs LD, Cookfarir DL, Rudick RA et al. (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 39:285-294
14. Wicks DAG, Tofts PS, Miller DH et al. (1992) Volume measurement of multiple sclerosis lesions with magnetic resonance imaging: a preliminary study. Neuroradiology 34: 475-479
15. Filippi M, Horsfield MA, Bressi S et al. (1995) Intra- and inter-observer agreement of brain MRI legion volume measurements in multiple sclerosis. A comparison of techniques. Brain 118: 1593-1600
16. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310
17. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ (1991) Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 54: 683-688
18. Filippi M, Gawne-Cain ML, Gasperini C et al. (1998) Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis. Neurology 50: 238-244